Kingdon Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Kingdon Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-118,278	Closed	-$13.7M	–	162
2016 Q3	$13.7M	Sell	118,278 -2,988	-2%	-$291K	0.63%	43
2016 Q2	$9.61M	Buy	121,266 +875	+0.7%	+$75.8K	0.53%	52
2016 Q1	$9.16M	Sell	120,391 -1,496	-1%	-$95.1K	0.5%	55
2015 Q4	$10.9M	Sell	121,887 -751	-0.6%	-$72.1K	0.53%	56
2015 Q3	$13.7M	Buy	122,638 +1,250	+1%	+$144K	0.66%	45
2015 Q2	$12.4M	Buy	121,388 +32,350	+36%	+$3.35M	0.48%	67
2015 Q1	$9.72M	Sell	89,038 -2,212	-2%	-$227K	0.41%	69
2014 Q4	$8.31M	Buy	91,250 +2,500	+3%	+$213K	0.36%	80
2014 Q3	$6.97M	Hold	88,750	–	–	0.31%	84
2014 Q2	$6.82M	Buy	88,750 +3,125	+4%	+$243K	0.26%	106
2014 Q1	$6.78M	Buy	+85,625	New	+$7.85M	0.35%	80

Other funds holding PLXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $107M AUM 37.25% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Middleton & Co Boston, Massachusetts $942M AUM 19.03% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kingdon Capital Management's PLXP Position: Q4 2016 in Review

Kingdon Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2016, closing a stake of 118,278 shares — an estimated $13.7M sold.

Kingdon Capital Management first reported a position in PLXP in Q1 2014 and held it in 11 quarters. The position peaked at $13.7M in Q3 2015. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

Kingdon Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Kingdon Capital Management sold 118,278 PLx Pharma Inc. Common Stock shares in Q4 2016, an estimated $13.7M.
Kingdon Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 11 quarters.
Kingdon Capital Management's PLx Pharma Inc. Common Stock position peaked at $13.7M in Q3 2015.
19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on Kingdon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.